CNRClinical Neuroscience Research3083-48992981-8133Bio-Byword Scientific Publishing Pty. Ltd.10.26689/cnr.v3i2.11150ArticleStudy on the Clinical Effect and Safety of Ginkgo Dipyridamole Injection Combined with Hyperbaric Oxygen in the Treatment of Ischemic Optic Neuropathyhttps://artdesignp.com/journal/CNR/3/2/10.26689/cnr.v3i2.11150LiZhiguang2025322025-05-28Objective: To analyze the effect of combining Ginkgo Dipyridamole Injection with hyperbaric oxygen in the treatment of patients with ischemic optic neuropathy, and to study the safety of this combined therapy. Methods: Sixty eligible patients were selected from the hospital as samples, with a fixed time period and randomized grouping. The control group received only Ginkgo Dipyridamole Injection as a therapeutic intervention, while the observation group received hyperbaric oxygen therapy in addition to Ginkgo Dipyridamole Injection. The effects of different treatment regimens were compared and analyzed. Results: The effective rate of treatment in the observation group was higher than that in the control group. After treatment, there were significant changes in visual field-related indicators compared to before treatment. In addition to a higher MS index in the observation group than in the control group, LV and MD indicators were lower in the observation group. The differences mentioned above were statistically significant (P < 0.05). There was no statistically significant difference in adverse reactions between the two groups (P > 0.05). Conclusion: Combining Ginkgo Dipyridamole Injection with hyperbaric oxygen can help patients with ischemic optic neuropathy achieve better treatment outcomes. Patients’ visual fields improved significantly after combined therapy, highlighting the effectiveness of this treatment approach. The safety of the combined therapy can be guaranteed, demonstrating the significant value of this treatment plan.

Wang YG, Wang BY, Zhang DC, 2021, Clinical Effect of Puerarin Glucose Injection Combined with Vincamine Sustained-release Capsules in the Treatment of Anterior Ischemic Optic Neuropathy. Drug Evaluation Research, 44(1): 116–121.

Lv Y, Wang Q, 2022, Clinical Observation on the Effect of Compound Xueshuantong Capsule Combined with Compound Anisodine Injection in The Treatment of Non-Arteritic Anterior Ischemic Optic Neuropathy. Chinese Journal of Modern Drug Application, 16(15): 45–48.

Liao L, Wang Y, Wei QP, 2022, Meta-analysis of the Efficacy and Safety of Compound Anisodine Injection in the Treatment of Anterior Ischemic Optic Neuropathy. Chinese Journal of Experimental Ophthalmology, 40(7): 645–650.

Chou YY, Ma J, Zhong Y, 2022, Neuroprotective and Nerve Regeneration Treatment Strategies for Non-Arteritic Anterior Ischemic Optic Neuropathy. Chinese Journal of Experimental Ophthalmology, 40(7): 675–679.

Guo LJ, Chen Y, 2022, Effects of Different Doses and Administration Methods of Glucocorticoids on Non-Arteritic Anterior Ischemic Optic Neuropathy. Chinese Journal of Ocular Trauma and Occupational Eye Disease, 44(11): 813–819.

Yang YQ, Ye JR, Bu SY, et al., 2022, Clinical Observation on the Effect of Self-Made Buqi Tongmu Decoction in the Treatment of Non-Arteritic Anterior Ischemic Optic Neuropathy of Qi and Blood Deficiency Type. Sichuan Journal of Traditional Chinese Medicine, 40(1): 164–167.

Zhang M, Wang XL, 2021, Exploring the Mechanism of Ginkgo Biloba in the Treatment of Non-Arteritic Anterior Ischemic Optic Neuropathy Based on Network Pharmacology. Recent Advances in Ophthalmology, 41(11): 1037–1042.

Liu M, Zheng YX, 2021, Effect of Modified Xuefu Zhuyu Decoction Combined with Acupuncture on Acute Anterior Ischemic Optic Neuropathy and its Influence on Vision, Visual Field, and Visual Evoked Potential. Modern Journal of Integrated Traditional Chinese and Western Medicine, 30(24): 2704–2707.

Sun WY, Liao X, Wang Y, et al., 2021, Systematic Evaluation of the Effectiveness of Glucocorticoids in the Treatment of Non-Arteritic Anterior Ischemic Optic Neuropathy. Chinese Journal of Fundus Diseases, 37(3): 224–230.

Ren Q, Li YF, Sun CB, et al., 2021, Clinical Observation of Hydrobromide Anisodine Injection in the Treatment of Non-Arteritic Anterior Ischemic Optic Neuropathy. China Pharmacist, 24(4): 709–712.

Shen L, Shi L, 2021, Observation on the Curative Effect of Compound Anisodine Combined with Mouse Nerve Growth Factor Injection in the Treatment of Ischemic Optic Neuropathy. Zhejiang Clinical Medicine, 23(6): 865–866.

Chen F, Gao F, Wang M, et al., 2021, Observation on the Curative Effect of Oral Glucocorticoids in the Treatment of Acute Non-Arteritic Anterior Ischemic Optic Neuropathy. Chinese Journal of Fundus Diseases, 37(10): 758–762.

Zhou WM, Cao WB, Chu JT, et al., 2021, Clinical Efficacy of Hyperbaric Oxygen Therapy in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy. Chinese Journal of Navigation Medicine and High Pressure Medicine, 28(1): 87–91.

Wu YB, Zhou ZB, Zhuo N, 2021, Clinical Efficacy of Injectable Mouse Nerve Growth Factor Combined with Traditional Medication in the Treatment of Anterior Ischemic Optic Neuropathy. Journal of Clinical Rational Drug Use, 14(3): 81–83.

Duan G, Xu XB, 2021, Clinical Efficacy and Safety Analysis of Ginkgo Biloba and Dipyridamole Injection Combined with Hyperbaric Oxygen Therapy in the Treatment of Ischemic Optic Neuropathy. Hainan Medical Journal, 32(21): 2779–2782.

Wang Y, 2021, Tongqiao Huoxue Decoction Combined with Deproteinized Calf Blood Extract Injection in the Treatment of 32 Cases of Anterior Ischemic Optic Neuropathy. Fujian Journal of Traditional Chinese Medicine, 52(2): 55–56.